| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 06/20/2000 | US6077659 Treating erythrocyte/photosensitizer composition with vitamin e, alpha-tocopherol phosphate, alpha-tocopherol succinate, or 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
| 06/15/2000 | WO2000033954A1 Methods of preparing and using electrostatically treated fluids |
| 06/15/2000 | WO2000033874A2 Boron neutron capture therapy using pre-targeting methods |
| 06/15/2000 | WO2000033833A1 Palladium-substituted bacteriochlorophyll derivatives and use thereof |
| 06/15/2000 | WO2000006244A3 Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy |
| 06/14/2000 | EP1007729A1 COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES |
| 06/14/2000 | EP1007533A1 Bioconjugates and delivery of bioactive agents |
| 06/13/2000 | US6074666 Liposome compositions of porphyrin photosensitizers |
| 06/13/2000 | US6074625 Using complex of boron isotope |
| 06/08/2000 | WO2000032121A1 Reduction, elimination, or stimulation of hair growth |
| 06/08/2000 | DE19851989A1 Novel biomimetic molecules containing iodine and tellurium useful as radiological therapeutic and diagnostic agents |
| 06/08/2000 | DE19851988A1 Novel biomimetic molecules containing iodine and tellurium useful as radiological therapeutic and diagnostic agents |
| 06/07/2000 | EP1005531A2 Method of treating leukocytes, leukocyte compositions and methods of use thereof |
| 06/07/2000 | EP1005375A1 Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes |
| 06/07/2000 | EP1005369A2 Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy |
| 06/07/2000 | EP1005267A1 Phototherapy based method for treating pathogens and composition for effecting same |
| 06/07/2000 | EP0855909A4 Radiosensitizing taxanes and their pharmaceutical preparations |
| 06/07/2000 | CN1255863A Green porphyrins as immunomodulators |
| 06/07/2000 | CN1255376A Method of enhancing crude drugs anti-tumour activity |
| 06/06/2000 | US6072038 Conjugates of texaphyrins |
| 06/06/2000 | US6071956 Treatment of tissues to reduce subsequent response to injury |
| 06/06/2000 | US6071944 Method of treatment of pigmented cancer cells utilizing photodynamic therapy |
| 06/06/2000 | US6071908 Radiation-activated cytotoxin therapy of neoplastic disease |
| 06/06/2000 | US6071495 Targeted gas and gaseous precursor-filled liposomes |
| 05/31/2000 | EP1003498A1 Di-aryl ethers and their derivatives as anti-cancer agents |
| 05/31/2000 | CN1255135A New class of benzoporphyrin derivative photoactive compounds |
| 05/31/2000 | CN1255063A Photosensitizer conjugates for pathogen targeting |
| 05/31/2000 | CN1255061A Use of chelerythrine and radiation for tumor therapy |
| 05/30/2000 | US6069140 Pharmaceutical compositions comprising texaphyrins |
| 05/30/2000 | US6068857 Microparticles containing active ingredients, agents containing these microparticles, their use for ultrasound-controlled release of active ingredients, as well as a process for their production |
| 05/25/2000 | WO2000029003A2 Method for preventing and reversing atherosclerosis in mammals |
| 05/25/2000 | WO2000028971A1 Nano-emulsion of 5-aminolevulinic acid |
| 05/25/2000 | WO2000028813A1 Treatment of myelogenous leukemia |
| 05/25/2000 | CA2348599A1 Method for preventing and reversing atherosclerosis in mammals |
| 05/24/2000 | EP1001811A1 Nanoscale particles having an iron oxide-containing core enveloped by at least two shells |
| 05/24/2000 | EP1001770A1 Tazarotene and uvb phototherapy treatment for psoriasis |
| 05/24/2000 | EP1001765A1 Internal two photon excitation device for delivery of pdt to diffuse abnormal cells |
| 05/24/2000 | CN1254339A Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 05/18/2000 | DE19852245A1 5-Aminolävulinsäure-Nanoemulsion 5-aminolevulinic acid nanoemulsions |
| 05/17/2000 | EP0858285A4 Microporation of human skin for drug delivery and monitoring applications |
| 05/17/2000 | EP0653911B1 Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen |
| 05/17/2000 | CN1253507A Acid-labile and enzymatically divisible dye structure for diagnosis with near infrared light and for therapy |
| 05/17/2000 | CN1253020A Physical preparation based on electronics gene and bioengineering, and its products |
| 05/16/2000 | US6063777 Iminochlorinaspartic acid derivatives |
| 05/11/2000 | WO2000026643A1 Method for non-invasive imaging oxygen distribution in multi-dimensions and apparatus therefor |
| 05/11/2000 | WO2000025830A2 Biomimetic elements containing iodine and/or tellurium, the production thereof and their use |
| 05/11/2000 | WO2000025829A2 Radiodense compositions |
| 05/11/2000 | WO2000025819A1 Enhanced radiation therapy |
| 05/11/2000 | WO2000025665A1 Method for improved imaging and photodynamic therapy |
| 05/11/2000 | CA2348536A1 Radiodense compositions |
| 05/11/2000 | CA2348527A1 Method for non-invasive imaging oxygen distribution in multi-dimensions and apparatus therefor |
| 05/11/2000 | CA2348094A1 Method for improved imaging and photodynamic therapy |
| 05/11/2000 | CA2347915A1 Enhanced radiation therapy |
| 05/09/2000 | US6060598 Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding |
| 05/04/2000 | WO1999066959A3 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
| 05/03/2000 | EP0996725A1 Human nk-3 related prostate specific gene-1 |
| 05/03/2000 | EP0996469A1 Methods of photoacoustic imaging |
| 05/03/2000 | EP0996465A1 Compositions and articles for reducing the effects of inflammation |
| 05/03/2000 | EP0625055B1 Use of fullerenes in diagnostic and/or therapeutic agents |
| 05/03/2000 | CN1252006A Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes |
| 05/02/2000 | US6057096 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 04/27/2000 | WO2000023117A1 Photosensitizer conjugates for targeting intracellular pathogens |
| 04/27/2000 | WO1999061085A9 Method and compositions for treatment of cancers |
| 04/27/2000 | WO1998048838A8 Compounds |
| 04/27/2000 | CA2347045A1 Photosensitizer conjugates for targeting intracellular pathogens |
| 04/26/2000 | EP0995448A1 Diagnostic agents and remedies for malignant tumors |
| 04/26/2000 | EP0994725A1 Thermodynamic adaptive phased array system for activating thermosensititve liposomes in targeted drug delivery |
| 04/25/2000 | US6054449 Photodynamic therapy |
| 04/20/2000 | WO2000021965A1 Substituted perhalogenated phthalocyanines |
| 04/20/2000 | WO2000021562A1 Method to prevent xenograft transplant rejection |
| 04/20/2000 | WO2000021561A1 Model and method for angiogenesis inhibition |
| 04/20/2000 | WO2000021509A2 Methods of treatment |
| 04/19/2000 | EP0760679B1 Photodynamic conjugates with biocidal properties |
| 04/13/2000 | WO2000020419A1 Photosensitizers for photodynamic applications |
| 04/13/2000 | WO2000020022A1 Methods for the treatment of cancer using cytokines in combination with low level doses of chemotherapy and/or radiotherapy |
| 04/13/2000 | CA2345580A1 Photosensitizers for photodynamic applications |
| 04/06/2000 | WO2000018468A1 Method, device and kit for performing gene therapy |
| 04/05/2000 | EP0989865A1 Apparatus and method for preparing radioactive medicines for administration |
| 04/05/2000 | EP0989825A2 Method and apparatus for administration of substances by ultrasound |
| 03/30/2000 | WO2000016806A1 Remedies for photochemotherapy |
| 03/30/2000 | WO2000016794A1 Neuroimmunophilins for selective neuronal radioprotection |
| 03/30/2000 | WO1999066959A9 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
| 03/30/2000 | DE19944695A1 Method for strengthening the antitumor activity of a crude drug containing polysaccharides comprises roasting the crude drug by far infrared rays followed by fermentation using microorganisms |
| 03/30/2000 | CA2345378A1 Neuroimmunophilins for selective neuronal radioprotection |
| 03/30/2000 | CA2342602A1 Remedies for photochemotherapy |
| 03/29/2000 | EP0989185A1 Method of cleaving specific nucleic acid sequence |
| 03/29/2000 | EP0988061A1 Methods for delivering bioactive agents |
| 03/29/2000 | EP0988060A2 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy |
| 03/28/2000 | US6043237 Use of photodynamic therapy for prevention of secondary cataracts |
| 03/28/2000 | US6042603 Method for improved selectivity in photo-activation of molecular agents |
| 03/23/2000 | WO1999062512A9 3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical substances containing the same, method for the production and use thereof in photodynamic therapy and mri diagnosis |
| 03/23/2000 | WO1999061085A3 Method and compositions for treatment of cancers |
| 03/23/2000 | DE19838377A1 Verfahren und Vorrichtung zur Extraktherstellung aus biologischem Material, dadurch hergestellte Extrakte und deren Verwendung Method and apparatus for manufacture of extracts from biological material, characterized Extracts prepared and their use |
| 03/22/2000 | EP0986401A1 P-selectin translocation to vascular epithelial lumen by ionizing radiation |
| 03/22/2000 | EP0986302A1 A method of treating cancer |
| 03/22/2000 | EP0772776B1 Superparamagnetic particles, process for their production and their use |
| 03/21/2000 | US6041253 Electroporation, vacuum or mechanical pressure. |
| 03/21/2000 | US6039757 In situ formed fenestrated stent |
| 03/21/2000 | US6039684 Non-lethal conditioning methods for the treatment of acquired immunodeficiency syndrome |
| 03/21/2000 | US6039557 Apparatus for making gas-filled vesicles of optimal size |